Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-27

FDA Approved: KYZATREX — Original Application (Marius Pharmaceuticals)

View source ↗

Summary

FDA approved KYZATREX (testosterone undecanoate) through an Original Application (NDA) by Marius Pharmaceuticals for testosterone replacement in adult males wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KYZATREX (Testosterone undecanoate)

Snippet

ORIG AP for KYZATREX (TESTOSTERONE UNDECANOATE)